Ustekinumab Terminated Phase 3 Trials for Palmo-Plantar Pustulosis / Palmo-Plantar Pustular Psoriasis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01091051Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis